SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 34 filers reported holding SATSUMA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 870,820 | $13,071,000 | 14.74% |
| RA Capital Management | 4,681,858 | $70,275,000 | 4.19% |
| Cormorant Asset Management, LP | 858,382 | $12,884,000 | 0.78% |
| Monashee Investment Management LLC | 62,500 | $938,000 | 0.43% |
| TPG Group Holdings (SBS) Advisors, Inc. | 3,771,878 | $56,616,000 | 0.42% |
| DC Investments Management, LLC | 35,502 | $533,000 | 0.31% |
| Eventide Asset Management | 425,000 | $6,379,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 610,000 | $9,156,000 | 0.02% |
| Weiss Asset Management LP | 14,150 | $212,000 | 0.02% |
| Zimmer Partners, LP | 100,000 | $1,501,000 | 0.02% |